A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential
- PMID: 28504078
- DOI: 10.1080/1028415X.2017.1327200
A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential
Abstract
Objectives: The growing rate of neurological disorders is a major concern in today's scenario. Today's research is focusing on therapeutic interventions providing benefits in these disorders. Presently, drugs of natural origin have gained more interest for the treatment of central nervous system disorders for their efficacy and less/ no side effects. This review is emphasizing the cited roles of Trigonella foenum graecum (fenugreek) and its constituents in different neurological manifestations.
Method: A review of the literature, relevant to the role of fenugreek and its major constituents including saponins and alkaloids in different neurological aspects and in delineating the health benefits, was conducted.
Results: The cited research acknowledged that fenugreek and its constituents exert positive influence on neurological health. Few studies have reported the beneficial role of fenugreek and its constituents like trigonelline in pathological symptoms of Alzheimer's disease. Similarly, other studies evidenced the neuroprotective, antidepressant, antianxiety as well as modulatory effect on cognitive functions and Parkinson's disease.
Discussion: Large populations are the sufferers of the neurological disorders, pointing the need for investigation of such therapeutic interventions which target and delay the underlying pathological hallmarks and exert positive influence on different neurological health problems. Hypolipidemic, hypoglycemic, antioxidant, and immunomodulatory effects of fenugreek and its constituents with their potential role in various neurological disorders were already reported. In future, it would be of even greater interest to further develop more effective dosage, supplementation period, and to evaluate the therapeutic potentials of fenugreek and its constituents in neurological disorders by exploring underlying cellular and molecular mechanisms.
Keywords: Alzheimer's disease; Depression; Fenugreek; Parkinson's disease; Trigonelline.
Similar articles
-
Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer's Disease.Curr Alzheimer Res. 2023;20(2):71-79. doi: 10.2174/1567205020666230525154300. Curr Alzheimer Res. 2023. PMID: 37231762 Review.
-
Recent Therapeutic Interventions of Fenugreek Seed: A Mechanistic Approach.Drug Res (Stuttg). 2021 Apr;71(4):180-192. doi: 10.1055/a-1320-0479. Epub 2020 Dec 30. Drug Res (Stuttg). 2021. PMID: 33378775 Review.
-
The Anti-hyperglycemic and Anti-hyperlipidemic Effects of Trigonella foenum-graecum L. Seeds on Fructose-induced Diabetic Wistar Rats.Plant Foods Hum Nutr. 2024 Dec 30;80(1):23. doi: 10.1007/s11130-024-01276-6. Plant Foods Hum Nutr. 2024. PMID: 39739074
-
A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion.Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600950. Epub 2017 Apr 27. Mol Nutr Food Res. 2017. PMID: 28266134 Review.
-
Amelioration of hyperglycemia and associated metabolic abnormalities by a combination of fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) in experimental diabetes.J Basic Clin Physiol Pharmacol. 2017 Sep 26;28(5):493-505. doi: 10.1515/jbcpp-2015-0140. J Basic Clin Physiol Pharmacol. 2017. PMID: 28599386
Cited by
-
Middle East Medicinal Plants in the Treatment of Diabetes: A Review.Molecules. 2021 Jan 31;26(3):742. doi: 10.3390/molecules26030742. Molecules. 2021. PMID: 33572627 Free PMC article. Review.
-
Fenugreek and Its Effects on Muscle Performance: A Systematic Review.J Pers Med. 2023 Feb 27;13(3):427. doi: 10.3390/jpm13030427. J Pers Med. 2023. PMID: 36983608 Free PMC article. Review.
-
Pre-clinical pharmacokinetic and pharmacodynamic modelling study of 4-hydroxyisoleucine using validated ultra-performance liquid chromatography-tandem mass spectrometry.RSC Adv. 2020 Feb 4;10(10):5525-5532. doi: 10.1039/c9ra08121f. eCollection 2020 Feb 4. RSC Adv. 2020. PMID: 35497432 Free PMC article.
-
Chemical Fingerprinting, Antioxidant, and Anti-Inflammatory Potential of Hydroethanolic Extract of Trigonella foenum-graecum.Antioxidants (Basel). 2022 Feb 11;11(2):364. doi: 10.3390/antiox11020364. Antioxidants (Basel). 2022. PMID: 35204245 Free PMC article.
-
Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders.Metab Brain Dis. 2023 Dec;38(8):2721-2733. doi: 10.1007/s11011-023-01304-5. Epub 2023 Oct 18. Metab Brain Dis. 2023. PMID: 37851136
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical